Skip to content

Public FDA record

Z-2672-2017: Proteus 235 and Proteus ONE proton therapy systems

Recall record Z-2672-2017 for Ion Beam Applications S.A.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2672-2017
Company in FDA record
Ion Beam Applications S.A.
FDA record creation date
Jul 3, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Recall is being initiated to address on-site software installations not being performed consistently with IBA standard operating procedures.

Source facts

Action
An Urgent Field Safety Notice MID-54097 was mailed to affected customers to inform that IBA plans to deploy a new software by March 2017 to correct the issue. Customers were reminded to follow standard protocol until the software updates are deployed.
Initiated
2016-05-18
Root cause
Employee error
Terminated
2019-02-08
Distribution
Products distributed to FL, VA, PA, OK, IL, NJ, WA, TN, LA, TX, South Korea, Germany, France, Czech Republic, Italy, Poland, and Sweden
Recall number
Z-2672-2017
Recall status
Terminated
CDRH record ID
156859
FDA record created
2017-07-03
Recall event number
77620

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗